Sorafenib Dose Ramp-Up in Hepatocellular Carcinoma (HCC)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David R Nelson, MD
University of Florida
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Florida Hepatology
Gainesville, Florida, United States
- Mayo Clinic
Jacksonville, Florida, United States
- Florida Hospital Transplant Center
Orlando, Florida, United States
- Tampa General Hospital
Tampa, Florida, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Henry Ford Health System
Detroit, Michigan, United States
- Drexel University College of Medicine
Philadelphia, Pennsylvania, United States
- University of Texas Health Science Center Houston
Houston, Texas, United States
- Brooke Army Medical Center
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 2010
- Primary completion
- 31 Jan 2014
- Completion
- 31 Mar 2014
- Last update posted
- 5 Mar 2015
- Registered enrollment
- 120
- Registry id
- NCT01203787
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.